APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gamma Globulin Therpeautic Agent

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gamma Globulin Therpeautic Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025198 pages

Choose your research edition.

Industry ResearchGamma Globulin Therpeautic Agent Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Gamma Globulin Therpeautic Agent Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Gamma Globulin Therpeautic Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gamma Globulin Therpeautic Agent Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Gamma Globulin Therpeautic Agent Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Gamma Globulin Therpeautic Agent market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Gamma Globulin Therpeautic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gamma Globulin Therpeautic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gamma Globulin Therpeautic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gamma Globulin Therpeautic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gamma Globulin Therpeautic Agent include ADMA Biologics, Baxter, Biotest, BPL, Grifols, Kedrion Biopharma, LFB Group, Octapharma and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gamma Globulin Therpeautic Agent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gamma Globulin Therpeautic Agent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gamma Globulin Therpeautic Agent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gamma Globulin Therpeautic Agent market size, projected growth trends, production technologies, key applications, and end-use industries.

Gamma Globulin Therpeautic Agent Segment by Company

ADMA Biologics

Baxter

Biotest

BPL

Grifols

Kedrion Biopharma

LFB Group

Octapharma

Takeda

Beijing Bohui Innovation Biotechnology

Hualan Biological

Pacific Shuanglin Bio-pharmacy

Shanghai RAAS

Sichuan Yuanda Shuyang

CBPO

Beijing Tiantan Biological

Shenzhen Weiguang Biological

CNBG

Gamma Globulin Therpeautic Agent Segment by Type

Gamma Globulin Liquid

Gamma Globulin Powder

Gamma Globulin Therpeautic Agent Segment by Application

Autoimmune Disease

Immunodeficiency

Acute Infection

Gamma Globulin Therpeautic Agent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gamma Globulin Therpeautic Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gamma Globulin Therpeautic Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gamma Globulin Therpeautic Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gamma Globulin Therpeautic Agent market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gamma Globulin Therpeautic Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Gamma Globulin Therpeautic Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Gamma Globulin Therpeautic Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Gamma Globulin Therpeautic Agent Industry Trends Table 2. Gamma Globulin Therpeautic Agent Industry Drivers Table 3. Gamma Globulin Therpeautic Agent Industry Opportunities and Challenges Table 4. Gamma Globulin Therpeautic Agent Industry Restraints Table 5. Global Gamma Globulin Therpeautic Agent Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Gamma Globulin Therpeautic Agent Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Gamma Globulin Therpeautic Agent Sales by Manufacturers (Kg) & (2021-2026) Table 8. Global Gamma Globulin Therpeautic Agent Sales Market Share by Manufacturers Table 9. Global Gamma Globulin Therpeautic Agent Average Sales Price (US$/g) of Manufacturers (2021-2026) Table 10. Global Gamma Globulin Therpeautic Agent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Gamma Globulin Therpeautic Agent Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Gamma Globulin Therpeautic Agent Manufacturers, Product Type & Application Table 13. Global Gamma Globulin Therpeautic Agent Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Gamma Globulin Therpeautic Agent by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Gamma Globulin Liquid Table 17. Major Manufacturers of Gamma Globulin Powder Table 18. Global Gamma Globulin Therpeautic Agent Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 19. Global Gamma Globulin Therpeautic Agent Sales by Type (2021-2026) & (Kg) Table 20. Global Gamma Globulin Therpeautic Agent Sales by Type (2027-2032) & (Kg) Table 21. Global Gamma Globulin Therpeautic Agent Sales Market Share by Type (2021-2026) Table 22. Global Gamma Globulin Therpeautic Agent Sales Market Share by Type (2027-2032) Table 23. Global Gamma Globulin Therpeautic Agent Revenue by Type 2021 VS 2025 VS 2032 (Kg) Table 24. Global Gamma Globulin Therpeautic Agent Revenue by Type (2021-2026) & (Kg) Table 25. Global Gamma Globulin Therpeautic Agent Revenue by Type (2027-2032) & (Kg) Table 26. Global Gamma Globulin Therpeautic Agent Revenue Market Share by Type (2021-2026) Table 27. Global Gamma Globulin Therpeautic Agent Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Autoimmune Disease Table 29. Major Manufacturers of Immunodeficiency Table 30. Major Manufacturers of Acute Infection Table 31. Global Gamma Globulin Therpeautic Agent Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 32. Global Gamma Globulin Therpeautic Agent Sales by Application (2021-2026) & (Kg) Table 33. Global Gamma Globulin Therpeautic Agent Sales by Application (2027-2032) & (Kg) Table 34. Global Gamma Globulin Therpeautic Agent Sales Market Share by Application (2021-2026) Table 35. Global Gamma Globulin Therpeautic Agent Sales Market Share by Application (2027-2032) Table 36. Global Gamma Globulin Therpeautic Agent Revenue by Application 2021 VS 2025 VS 2032 (Kg) Table 37. Global Gamma Globulin Therpeautic Agent Revenue by Application (2021-2026) & (Kg) Table 38. Global Gamma Globulin Therpeautic Agent Revenue by Application (2027-2032) & (Kg) Table 39. Global Gamma Globulin Therpeautic Agent Revenue Market Share by Application (2021-2026) Table 40. Global Gamma Globulin Therpeautic Agent Revenue Market Share by Application (2027-2032) Table 41. Global Gamma Globulin Therpeautic Agent Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 42. Global Gamma Globulin Therpeautic Agent Sales by Region (2021-2026) & (Kg) Table 43. Global Gamma Globulin Therpeautic Agent Sales Market Share by Region (2021-2026) Table 44. Global Gamma Globulin Therpeautic Agent Sales Forecasted by Region (2027-2032) & (Kg) Table 45. Global Gamma Globulin Therpeautic Agent Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Gamma Globulin Therpeautic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 47. North America Gamma Globulin Therpeautic Agent Sales by Country (2021-2026) & (Kg) Table 48. North America Gamma Globulin Therpeautic Agent Sales by Country (2027-2032) & (Kg) Table 49. Europe Gamma Globulin Therpeautic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 50. Europe Gamma Globulin Therpeautic Agent Sales by Country (2021-2026) & (Kg) Table 51. Europe Gamma Globulin Therpeautic Agent Sales by Country (2027-2032) & (Kg) Table 52. Asia Pacific Gamma Globulin Therpeautic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 53. Asia Pacific Gamma Globulin Therpeautic Agent Sales by Country (2021-2026) & (Kg) Table 54. Asia Pacific Gamma Globulin Therpeautic Agent Sales by Country (2027-2032) & (Kg) Table 55. South America, Middle East and Africa Gamma Globulin Therpeautic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 56. South America, Middle East and Africa Gamma Globulin Therpeautic Agent Sales by Country (2021-2026) & (Kg) Table 57. South America, Middle East and Africa Gamma Globulin Therpeautic Agent Sales by Country (2027-2032) & (Kg) Table 58. Global Gamma Globulin Therpeautic Agent Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Gamma Globulin Therpeautic Agent Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Gamma Globulin Therpeautic Agent Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Gamma Globulin Therpeautic Agent Revenue Market Share by Region (2021-2026) Table 62. Global Gamma Globulin Therpeautic Agent Revenue Market Share by Region (2027-2032) Table 63. ADMA Biologics Company Information Table 64. ADMA Biologics Business Overview Table 65. ADMA Biologics Gamma Globulin Therpeautic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. ADMA Biologics Gamma Globulin Therpeautic Agent Product Portfolio Table 67. ADMA Biologics Recent Development Table 68. Baxter Company Information Table 69. Baxter Business Overview Table 70. Baxter Gamma Globulin Therpeautic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Baxter Gamma Globulin Therpeautic Agent Product Portfolio Table 72. Baxter Recent Development Table 73. Biotest Company Information Table 74. Biotest Business Overview Table 75. Biotest Gamma Globulin Therpeautic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Biotest Gamma Globulin Therpeautic Agent Product Portfolio Table 77. Biotest Recent Development Table 78. BPL Company Information Table 79. BPL Business Overview Table 80. BPL Gamma Globulin Therpeautic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. BPL Gamma Globulin Therpeautic Agent Product Portfolio Table 82. BPL Recent Development Table 83. Grifols Company Information Table 84. Grifols Business Overview Table 85. Grifols Gamma Globulin Therpeautic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Grifols Gamma Globulin Therpeautic Agent Product Portfolio Table 87. Grifols Recent Development Table 88. Kedrion Biopharma Company Information Table 89. Kedrion Biopharma Business Overview Table 90. Kedrion Biopharma Gamma Globulin Therpeautic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Kedrion Biopharma Gamma Globulin Therpeautic Agent Product Portfolio Table 92. Kedrion Biopharma Recent Development Table 93. LFB Group Company Information Table 94. LFB Group Business Overview Table 95. LFB Group Gamma Globulin Therpeautic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. LFB Group Gamma Globulin Therpeautic Agent Product Portfolio Table 97. LFB Group Recent Development Table 98. Octapharma Company Information Table 99. Octapharma Business Overview Table 100. Octapharma Gamma Globulin Therpeautic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Octapharma Gamma Globulin Therpeautic Agent Product Portfolio Table 102. Octapharma Recent Development Table 103. Takeda Company Information Table 104. Takeda Business Overview Table 105. Takeda Gamma Globulin Therpeautic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Takeda Gamma Globulin Therpeautic Agent Product Portfolio Table 107. Takeda Recent Development Table 108. Beijing Bohui Innovation Biotechnology Company Information Table 109. Beijing Bohui Innovation Biotechnology Business Overview Table 110. Beijing Bohui Innovation Biotechnology Gamma Globulin Therpeautic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Beijing Bohui Innovation Biotechnology Gamma Globulin Therpeautic Agent Product Portfolio Table 112. Beijing Bohui Innovation Biotechnology Recent Development Table 113. Hualan Biological Company Information Table 114. Hualan Biological Business Overview Table 115. Hualan Biological Gamma Globulin Therpeautic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Hualan Biological Gamma Globulin Therpeautic Agent Product Portfolio Table 117. Hualan Biological Recent Development Table 118. Pacific Shuanglin Bio-pharmacy Company Information Table 119. Pacific Shuanglin Bio-pharmacy Business Overview Table 120. Pacific Shuanglin Bio-pharmacy Gamma Globulin Therpeautic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Pacific Shuanglin Bio-pharmacy Gamma Globulin Therpeautic Agent Product Portfolio Table 122. Pacific Shuanglin Bio-pharmacy Recent Development Table 123. Shanghai RAAS Company Information Table 124. Shanghai RAAS Business Overview Table 125. Shanghai RAAS Gamma Globulin Therpeautic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Shanghai RAAS Gamma Globulin Therpeautic Agent Product Portfolio Table 127. Shanghai RAAS Recent Development Table 128. Sichuan Yuanda Shuyang Company Information Table 129. Sichuan Yuanda Shuyang Business Overview Table 130. Sichuan Yuanda Shuyang Gamma Globulin Therpeautic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Sichuan Yuanda Shuyang Gamma Globulin Therpeautic Agent Product Portfolio Table 132. Sichuan Yuanda Shuyang Recent Development Table 133. CBPO Company Information Table 134. CBPO Business Overview Table 135. CBPO Gamma Globulin Therpeautic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. CBPO Gamma Globulin Therpeautic Agent Product Portfolio Table 137. CBPO Recent Development Table 138. Beijing Tiantan Biological Company Information Table 139. Beijing Tiantan Biological Business Overview Table 140. Beijing Tiantan Biological Gamma Globulin Therpeautic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Beijing Tiantan Biological Gamma Globulin Therpeautic Agent Product Portfolio Table 142. Beijing Tiantan Biological Recent Development Table 143. Shenzhen Weiguang Biological Company Information Table 144. Shenzhen Weiguang Biological Business Overview Table 145. Shenzhen Weiguang Biological Gamma Globulin Therpeautic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Shenzhen Weiguang Biological Gamma Globulin Therpeautic Agent Product Portfolio Table 147. Shenzhen Weiguang Biological Recent Development Table 148. CNBG Company Information Table 149. CNBG Business Overview Table 150. CNBG Gamma Globulin Therpeautic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. CNBG Gamma Globulin Therpeautic Agent Product Portfolio Table 152. CNBG Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Gamma Globulin Therpeautic Agent Distributors List Table 156. Gamma Globulin Therpeautic Agent Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Gamma Globulin Therpeautic Agent Product Image Figure 2. Global Gamma Globulin Therpeautic Agent Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gamma Globulin Therpeautic Agent Market Size (2021-2032) & (US$ Million) Figure 4. Global Gamma Globulin Therpeautic Agent Sales (2021-2032) & (Kg) Figure 5. Global Gamma Globulin Therpeautic Agent Average Price (US$/g) & (2021-2032) Figure 6. Global Top 5 and 10 Gamma Globulin Therpeautic Agent Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Gamma Globulin Liquid Image Figure 9. Gamma Globulin Powder Image Figure 10. Global Gamma Globulin Therpeautic Agent Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 11. Global Gamma Globulin Therpeautic Agent Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Gamma Globulin Therpeautic Agent Sales Market Share by Type (2021-2032) Figure 13. Global Gamma Globulin Therpeautic Agent Revenue by Type (2021 VS 2025 VS 2032) & (Kg) Figure 14. Global Gamma Globulin Therpeautic Agent Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Gamma Globulin Therpeautic Agent Revenue Market Share by Type (2021-2032) Figure 16. Autoimmune Disease Image Figure 17. Immunodeficiency Image Figure 18. Acute Infection Image Figure 19. Global Gamma Globulin Therpeautic Agent Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 20. Global Gamma Globulin Therpeautic Agent Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Gamma Globulin Therpeautic Agent Sales Market Share by Application (2021-2032) Figure 22. Global Gamma Globulin Therpeautic Agent Revenue by Application (2021 VS 2025 VS 2032) & (Kg) Figure 23. Global Gamma Globulin Therpeautic Agent Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Gamma Globulin Therpeautic Agent Revenue Market Share by Application (2021-2032) Figure 25. North America Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 26. North America Gamma Globulin Therpeautic Agent Sales Market Share by Country (2021-2032) Figure 27. U.S. Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 28. Canada Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 29. Mexico Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 30. Europe Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 31. Europe Gamma Globulin Therpeautic Agent Sales Market Share by Country (2021-2032) Figure 32. Germany Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 33. France Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 34. U.K. Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 35. Italy Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 36. Netherlands Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 37. Asia Pacific Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 38. Asia Pacific Gamma Globulin Therpeautic Agent Sales Market Share by Country (2021-2032) Figure 39. China Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 40. Japan Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 41. South Korea Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 42. Southeast Asia Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 43. India Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 44. Australia Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 45. South America, Middle East and Africa Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 46. South America, Middle East and Africa Gamma Globulin Therpeautic Agent Sales Market Share by Country (2021-2032) Figure 47. Brazil Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 48. South Africa Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 49. Saudi Arabia Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 50. Turkey Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 51. Argentina Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 52. UAE Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 53. Egypt Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 54. Chile Gamma Globulin Therpeautic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 55. Global Gamma Globulin Therpeautic Agent Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Gamma Globulin Therpeautic Agent Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Gamma Globulin Therpeautic Agent Revenue (2021-2032) & (US$ Million) Figure 58. North America Gamma Globulin Therpeautic Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Gamma Globulin Therpeautic Agent Revenue (2021-2032) & (US$ Million) Figure 60. Europe Gamma Globulin Therpeautic Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Gamma Globulin Therpeautic Agent Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Gamma Globulin Therpeautic Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Gamma Globulin Therpeautic Agent Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Gamma Globulin Therpeautic Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Gamma Globulin Therpeautic Agent Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Gamma Globulin Therpeautic Agent Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Gamma Globulin Liquid
  • Gamma Globulin Powder
Applications
  • Autoimmune Disease
  • Immunodeficiency
  • Acute Infection
Companies covered
  • ADMA Biologics
  • Baxter
  • Biotest
  • BPL
  • Grifols
  • Kedrion Biopharma
  • LFB Group
  • Octapharma
  • Takeda
  • Beijing Bohui Innovation Biotechnology
  • Hualan Biological
  • Pacific Shuanglin Bio-pharmacy
  • Shanghai RAAS
  • Sichuan Yuanda Shuyang
  • CBPO
  • Beijing Tiantan Biological
  • Shenzhen Weiguang Biological
  • CNBG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Gamma Globulin Therpeautic Agent Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Gamma Globulin Therpeautic Agent Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Gamma Globulin Therpeautic Agent Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Gamma Globulin Therpeautic Agent Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Gamma Globulin Therpeautic Agent Market Dynamics
  1. 2.1 Gamma Globulin Therpeautic Agent Industry Trends
  2. 2.2 Gamma Globulin Therpeautic Agent Industry Drivers
  3. 2.3 Gamma Globulin Therpeautic Agent Industry Opportunities and Challenges
  4. 2.4 Gamma Globulin Therpeautic Agent Industry Restraints
3 Gamma Globulin Therpeautic Agent Market by Manufacturers
  1. 3.1 Global Gamma Globulin Therpeautic Agent Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Gamma Globulin Therpeautic Agent Sales by Manufacturers (2021-2026)
  3. 3.3 Global Gamma Globulin Therpeautic Agent Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Gamma Globulin Therpeautic Agent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gamma Globulin Therpeautic Agent Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Gamma Globulin Therpeautic Agent Manufacturers, Product Type & Application
  7. 3.7 Global Gamma Globulin Therpeautic Agent Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gamma Globulin Therpeautic Agent Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gamma Globulin Therpeautic Agent Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gamma Globulin Therpeautic Agent Tier 1, Tier 2, and Tier 3
4 Gamma Globulin Therpeautic Agent Market by Type
  1. 4.1 Gamma Globulin Therpeautic Agent Type Introduction
  2. 4.1.1 Gamma Globulin Liquid
  3. 4.1.2 Gamma Globulin Powder
  4. 4.2 Global Gamma Globulin Therpeautic Agent Sales by Type
  5. 4.2.1 Global Gamma Globulin Therpeautic Agent Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Gamma Globulin Therpeautic Agent Sales by Type (2021-2032)
  7. 4.2.3 Global Gamma Globulin Therpeautic Agent Sales Market Share by Type (2021-2032)
  8. 4.3 Global Gamma Globulin Therpeautic Agent Revenue by Type
  9. 4.3.1 Global Gamma Globulin Therpeautic Agent Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Gamma Globulin Therpeautic Agent Revenue by Type (2021-2032)
  11. 4.3.3 Global Gamma Globulin Therpeautic Agent Revenue Market Share by Type (2021-2032)
5 Gamma Globulin Therpeautic Agent Market by Application
  1. 5.1 Gamma Globulin Therpeautic Agent Application Introduction
  2. 5.1.1 Autoimmune Disease
  3. 5.1.2 Immunodeficiency
  4. 5.1.3 Acute Infection
  5. 5.2 Global Gamma Globulin Therpeautic Agent Sales by Application
  6. 5.2.1 Global Gamma Globulin Therpeautic Agent Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gamma Globulin Therpeautic Agent Sales by Application (2021-2032)
  8. 5.2.3 Global Gamma Globulin Therpeautic Agent Sales Market Share by Application (2021-2032)
  9. 5.3 Global Gamma Globulin Therpeautic Agent Revenue by Application
  10. 5.3.1 Global Gamma Globulin Therpeautic Agent Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Gamma Globulin Therpeautic Agent Revenue by Application (2021-2032)
  12. 5.3.3 Global Gamma Globulin Therpeautic Agent Revenue Market Share by Application (2021-2032)
6 Global Gamma Globulin Therpeautic Agent Sales by Region
  1. 6.1 Global Gamma Globulin Therpeautic Agent Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gamma Globulin Therpeautic Agent Sales by Region (2021-2032)
  3. 6.2.1 Global Gamma Globulin Therpeautic Agent Sales by Region (2021-2026)
  4. 6.2.2 Global Gamma Globulin Therpeautic Agent Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Gamma Globulin Therpeautic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Gamma Globulin Therpeautic Agent Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Gamma Globulin Therpeautic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Gamma Globulin Therpeautic Agent Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Gamma Globulin Therpeautic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Gamma Globulin Therpeautic Agent Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Gamma Globulin Therpeautic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Gamma Globulin Therpeautic Agent Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Gamma Globulin Therpeautic Agent Revenue by Region
  1. 7.1 Global Gamma Globulin Therpeautic Agent Revenue by Region
  2. 7.1.1 Global Gamma Globulin Therpeautic Agent Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Gamma Globulin Therpeautic Agent Revenue by Region (2021-2026)
  4. 7.1.3 Global Gamma Globulin Therpeautic Agent Revenue by Region (2027-2032)
  5. 7.1.4 Global Gamma Globulin Therpeautic Agent Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Gamma Globulin Therpeautic Agent Revenue (2021-2032)
  8. 7.2.2 North America Gamma Globulin Therpeautic Agent Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Gamma Globulin Therpeautic Agent Revenue (2021-2032)
  11. 7.3.2 Europe Gamma Globulin Therpeautic Agent Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Gamma Globulin Therpeautic Agent Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Gamma Globulin Therpeautic Agent Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Gamma Globulin Therpeautic Agent Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Gamma Globulin Therpeautic Agent Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 ADMA Biologics
  2. 8.1.1 ADMA Biologics Company Information
  3. 8.1.2 ADMA Biologics Business Overview
  4. 8.1.3 ADMA Biologics Gamma Globulin Therpeautic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ADMA Biologics Gamma Globulin Therpeautic Agent Product Portfolio
  6. 8.1.5 ADMA Biologics Recent Developments
  7. 8.2 Baxter
  8. 8.2.1 Baxter Company Information
  9. 8.2.2 Baxter Business Overview
  10. 8.2.3 Baxter Gamma Globulin Therpeautic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Baxter Gamma Globulin Therpeautic Agent Product Portfolio
  12. 8.2.5 Baxter Recent Developments
  13. 8.3 Biotest
  14. 8.3.1 Biotest Company Information
  15. 8.3.2 Biotest Business Overview
  16. 8.3.3 Biotest Gamma Globulin Therpeautic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Biotest Gamma Globulin Therpeautic Agent Product Portfolio
  18. 8.3.5 Biotest Recent Developments
  19. 8.4 BPL
  20. 8.4.1 BPL Company Information
  21. 8.4.2 BPL Business Overview
  22. 8.4.3 BPL Gamma Globulin Therpeautic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BPL Gamma Globulin Therpeautic Agent Product Portfolio
  24. 8.4.5 BPL Recent Developments
  25. 8.5 Grifols
  26. 8.5.1 Grifols Company Information
  27. 8.5.2 Grifols Business Overview
  28. 8.5.3 Grifols Gamma Globulin Therpeautic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Grifols Gamma Globulin Therpeautic Agent Product Portfolio
  30. 8.5.5 Grifols Recent Developments
  31. 8.6 Kedrion Biopharma
  32. 8.6.1 Kedrion Biopharma Company Information
  33. 8.6.2 Kedrion Biopharma Business Overview
  34. 8.6.3 Kedrion Biopharma Gamma Globulin Therpeautic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Kedrion Biopharma Gamma Globulin Therpeautic Agent Product Portfolio
  36. 8.6.5 Kedrion Biopharma Recent Developments
  37. 8.7 LFB Group
  38. 8.7.1 LFB Group Company Information
  39. 8.7.2 LFB Group Business Overview
  40. 8.7.3 LFB Group Gamma Globulin Therpeautic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 LFB Group Gamma Globulin Therpeautic Agent Product Portfolio
  42. 8.7.5 LFB Group Recent Developments
  43. 8.8 Octapharma
  44. 8.8.1 Octapharma Company Information
  45. 8.8.2 Octapharma Business Overview
  46. 8.8.3 Octapharma Gamma Globulin Therpeautic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Octapharma Gamma Globulin Therpeautic Agent Product Portfolio
  48. 8.8.5 Octapharma Recent Developments
  49. 8.9 Takeda
  50. 8.9.1 Takeda Company Information
  51. 8.9.2 Takeda Business Overview
  52. 8.9.3 Takeda Gamma Globulin Therpeautic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Takeda Gamma Globulin Therpeautic Agent Product Portfolio
  54. 8.9.5 Takeda Recent Developments
  55. 8.10 Beijing Bohui Innovation Biotechnology
  56. 8.10.1 Beijing Bohui Innovation Biotechnology Company Information
  57. 8.10.2 Beijing Bohui Innovation Biotechnology Business Overview
  58. 8.10.3 Beijing Bohui Innovation Biotechnology Gamma Globulin Therpeautic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Beijing Bohui Innovation Biotechnology Gamma Globulin Therpeautic Agent Product Portfolio
  60. 8.10.5 Beijing Bohui Innovation Biotechnology Recent Developments
  61. 8.11 Hualan Biological
  62. 8.11.1 Hualan Biological Company Information
  63. 8.11.2 Hualan Biological Business Overview
  64. 8.11.3 Hualan Biological Gamma Globulin Therpeautic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hualan Biological Gamma Globulin Therpeautic Agent Product Portfolio
  66. 8.11.5 Hualan Biological Recent Developments
  67. 8.12 Pacific Shuanglin Bio-pharmacy
  68. 8.12.1 Pacific Shuanglin Bio-pharmacy Company Information
  69. 8.12.2 Pacific Shuanglin Bio-pharmacy Business Overview
  70. 8.12.3 Pacific Shuanglin Bio-pharmacy Gamma Globulin Therpeautic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Pacific Shuanglin Bio-pharmacy Gamma Globulin Therpeautic Agent Product Portfolio
  72. 8.12.5 Pacific Shuanglin Bio-pharmacy Recent Developments
  73. 8.13 Shanghai RAAS
  74. 8.13.1 Shanghai RAAS Company Information
  75. 8.13.2 Shanghai RAAS Business Overview
  76. 8.13.3 Shanghai RAAS Gamma Globulin Therpeautic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Shanghai RAAS Gamma Globulin Therpeautic Agent Product Portfolio
  78. 8.13.5 Shanghai RAAS Recent Developments
  79. 8.14 Sichuan Yuanda Shuyang
  80. 8.14.1 Sichuan Yuanda Shuyang Company Information
  81. 8.14.2 Sichuan Yuanda Shuyang Business Overview
  82. 8.14.3 Sichuan Yuanda Shuyang Gamma Globulin Therpeautic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Sichuan Yuanda Shuyang Gamma Globulin Therpeautic Agent Product Portfolio
  84. 8.14.5 Sichuan Yuanda Shuyang Recent Developments
  85. 8.15 CBPO
  86. 8.15.1 CBPO Company Information
  87. 8.15.2 CBPO Business Overview
  88. 8.15.3 CBPO Gamma Globulin Therpeautic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CBPO Gamma Globulin Therpeautic Agent Product Portfolio
  90. 8.15.5 CBPO Recent Developments
  91. 8.16 Beijing Tiantan Biological
  92. 8.16.1 Beijing Tiantan Biological Company Information
  93. 8.16.2 Beijing Tiantan Biological Business Overview
  94. 8.16.3 Beijing Tiantan Biological Gamma Globulin Therpeautic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Beijing Tiantan Biological Gamma Globulin Therpeautic Agent Product Portfolio
  96. 8.16.5 Beijing Tiantan Biological Recent Developments
  97. 8.17 Shenzhen Weiguang Biological
  98. 8.17.1 Shenzhen Weiguang Biological Company Information
  99. 8.17.2 Shenzhen Weiguang Biological Business Overview
  100. 8.17.3 Shenzhen Weiguang Biological Gamma Globulin Therpeautic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Shenzhen Weiguang Biological Gamma Globulin Therpeautic Agent Product Portfolio
  102. 8.17.5 Shenzhen Weiguang Biological Recent Developments
  103. 8.18 CNBG
  104. 8.18.1 CNBG Company Information
  105. 8.18.2 CNBG Business Overview
  106. 8.18.3 CNBG Gamma Globulin Therpeautic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 CNBG Gamma Globulin Therpeautic Agent Product Portfolio
  108. 8.18.5 CNBG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gamma Globulin Therpeautic Agent Value Chain Analysis
  2. 9.1.1 Gamma Globulin Therpeautic Agent Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gamma Globulin Therpeautic Agent Production Mode & Process
  6. 9.2 Gamma Globulin Therpeautic Agent Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gamma Globulin Therpeautic Agent Distributors
  9. 9.2.3 Gamma Globulin Therpeautic Agent Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst